PRTG
PFE icon

Post Resch Tallon Group’s Pfizer PFE Stock Holding History

Post Resch Tallon Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$735K Buy
30,542
+1
+0% +$26 0.51% 42
2026
Q1 		$864K Buy
30,541
+15
+0% +$399 0.7% 36
2025
Q4 		$760K Buy
30,526
+14,065
+85% +$355K 0.64% 37
2025
Q3 		$419K Hold
16,461
– – 0.37% 52
2025
Q2 		$399K Sell
16,461
-650
-4% -$15.2K 0.38% 50
2025
Q1 		$421K Sell
17,111
-2,003
-10% -$52.4K 0.43% 47
2024
Q4 		$509K Buy
+19,114
New +$518K 0.49% 43

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Post Resch Tallon Group's PFE Position: Q2 2026 in Review

Post Resch Tallon Group increased its Pfizer (PFE) stake by 0% in Q2 2026, buying an estimated $26 and bringing the position to 30,542 shares worth $735K. The position accounts for 0.51% of the portfolio, ranked #42.

Post Resch Tallon Group first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $864K in Q1 2026. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Post Resch Tallon Group held 30,542 shares of Pfizer worth $735K as of Q2 2026.
  • Post Resch Tallon Group bought 1 Pfizer share in Q2 2026, an estimated $26.
  • Pfizer made up 0.51% of Post Resch Tallon Group's portfolio in Q2 2026, its #42 holding.
  • Post Resch Tallon Group first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Post Resch Tallon Group's Pfizer position peaked at $864K in Q1 2026.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Post Resch Tallon Group's 13F filing for Q2 2026, filed 7 Jul 2026.